Abstract: A bone implant composite comprising a collagen matrix and a calcium-based mineral, the calcium-based mineral having a particle size of 25-2000 ?m and being interspersed in the collagen matrix; wherein the bone implant composite contains 3-60% by weight the collagen matrix and 40-97% by weight the calcium-based mineral, and has a pore size of 50-500 ?m, a density range of 0.02-0.8 g/cm3, and a tensile strength range of 0.4-100 kg/cm2. Also disclosed are methods of preparing the above-described composite.

Abstract: A toner cartridge includes a casing provided at a bottom side thereof with an outlet, a sliding member slidably mounted on the casing, and a retaining member pivotally mounted on the casing. The sliding member is movable relative to the casing between a first position where the outlet is closed by the sliding member and a second position where the outlet is opened. The retaining member is pivotable relative to the casing between a third position where the retaining member is engaged with the sliding member to lock the sliding member at the first position, and a forth position where the retaining member is disengaged from the sliding member such that the sliding member is moveable to the second position to open the outlet. The toner cartridge has the advantage of preventing leakage of toner due to unintentional movement of the sliding member.

Abstract: A bone implant composite comprising a collagen matrix and a calcium-based mineral, the calcium-based mineral having a particle size of 25-2000 ?m and being interspersed in the collagen matrix; wherein the bone implant composite contains 3-60% by weight the collagen matrix and 40-97% by weight the calcium-based mineral, and has a pore size of 50-500 ?m, a density range of 0.02-0.8 g/cm3, and a tensile strength range of 0.4-100 kg/cm2. Also disclosed are methods of preparing the above-described composite.

Abstract: A cell occlusion sheet membrane adapted for repairing a damaged meningeal tissue. The sheet membrane contains a layer of cross-linked, oriented biopolymeric fibers that has a thickness of 0.1 mm to 3.0 mm, a density of 0.1 g/cm3 to 1.2 g/cm3, a hydrothermal shrinkage temperature of 45° C. to 80° C., a suture pullout strength of 0.1 kg to 5 kg, a tensile strength of 10 kg/cm2 to 150 kg/cm2, and permeability to molecules having molecular weights of 200 to 300,000 daltons. Also disclosed is a method for making the membrane.

Abstract: A wafer carrier. The wafer carrier includes a container and a plate, wherein the container has an inner wall and the plate is disposed in the vicinity of the inner wall of an upper portion of the container.

Abstract: A lid to selectively plug or unplug a discharge mouth of a toner container mountable to an image forming apparatus for replenishing a toner. In one embodiment, a lid has a body member having a bottom portion with an opening, a lug member having a body portion having a first end portion, and a base member having an opening. The body portion of the lug member is sized to be received into the opening of the bottom portion of the body member and into the opening of the base member to engage the body member with the base member. The body portion of the lug member is received into the opening of the bottom portion of the body member and into the opening of the base member, the first end portion of the body portion of the lug member snaggingly fits through the opening of the base member.

Abstract: A method for identifying a drifted dose integrator in an implantation system and an implantation system are provided. The implantation system includes a first dose integrator and a second dose integrator. The first dose integrator includes a first input configured to receive a first current generated from charges carried by implanted ions in a wafer, and a first output configured to output a first accumulated dosage value. The second dose integrator includes a second dose integrator including a second input configured to receive a second current generated from the charges carried by the implanted ions in the wafer, and a second output configured to output a second accumulated dosage value. The implantation system further includes a processing unit comparing the first accumulated dosage value and the second accumulated dosage value to detect a drift in one of the first and the second dose integrators.

Abstract: An air supply system for a clean room with a critical machine. An intake duct connects the exterior of the clean room to a make-up air unit, and is configured to transport external air into the make-up air unit. A first air duct connects the make-up air unit to an air conditioning cabinet including a first chemical filter, and is configured to transport the air flowing through the make-up air unit into the air conditioning cabinet. The first chemical filter removes airborne molecular contamination from the air transported into the air conditioning cabinet. A second air duct connects the air conditioning cabinet to the critical machine, and is configured to transport the air flowing through the first chemical filter of the air conditioning cabinet into the critical machine. An exhaust duct connects the critical machine to the exterior of the clean room, discharging waste gas produced in the critical machine.

Abstract: The invention provides a novel microorganism Pseudonocardia sp. RMRC PAH4 characterized in that it is able to degrade high concentration of quinoline by enrichment culture, shows a high tolerance to compactin-sodium and possesses a high hydroxylation activity of converting compactin-sodium to pravastatin-sodium. The invention relates also a process for converting compactin-sodium into pravastatin-sodium by fermenting said novel microorganism Pseudonocardia sp. RMRC PAH4. Pravastain-sodium is a potent cholesterol-lowering agent used in treatment for hypercholesterolemia.

Abstract: A process for purifying and preparing highly pure acarbose from acarbose-containing fermentation broth. The acarbose is purified through steps of alcohol precipitation, a strongly acidic cation exchanger chromatography and an immobolized enzyme affinity chromatography. Acarbose is generally applied in treating diabetes.

Abstract: A toner cartridge includes a housing, which has a receiving portion, a tubular portion, a first accommodating chamber defined in the tubular portion, a second accommodating chamber defined in the receiving portion in communication with the first accommodating chamber, and an outlet formed in the tubular portion in communication with the first accommodating chamber and the outside of the housing, an inner tube, which is rotatably mounted in the first accommodating chamber of the housing and which has plate portions and a slot communicatable with the outlet, and a seal, which is fixedly provided at an outer side of the inner tube and attachable to an inner surface of the tubular portion to prevent leakage of toner and which has a slot in communication with the slot of the inner tube.

Abstract: A toner cartridge includes a housing, which has a receiving portion, a tubular portion, a first accommodating chamber defined in the tubular portion, a second accommodating chamber defined in the receiving portion in communication with the first accommodating chamber, and an outlet formed in the tubular portion in communication with the first accommodating chamber and the outside of the housing, an inner tube, which is rotatably mounted in the first accommodating chamber of the housing and which has plate portions and a slot communicatable with the outlet, and a seal, which is fixedly provided at an outer side of the inner tube and attachable to an inner surface of the tubular portion to prevent leakage of toner and which has a slot in communication with the slot of the inner tube.

Abstract: A toner cartridge includes a housing, which has a first chamber and a second chamber, a rotary member mounted in the first chamber and rotatable relative to the housing by an external rotary driving force, a first magnet fixedly fastened to the rotary member, an axial motion member mounted in the second chamber, and a second magnet, which is fixedly provided at the bottom side of the axial motion member for acting with the first magnet to force the axial motion member to reciprocate.

Abstract: The present invention relates to a method for increasing the grain size of a polysilicon layer, which includes exposing a silicon oxide wafer in a deposition chamber to an amount, effective for the purpose, of nitrogen at a flow rate of at least about 240 standard liters per minute (slm). The instant invention further relates to a method for inhibiting the formation of a polysilicon seed in a furnace, which includes the treatment as noted above. The invention also relates to a method for forming a polysilicon layer, including: forming a silicon oxide layer on a substrate, the silicon oxide layer having a plurality of oxygen molecules therein; exposing the silicon oxide layer to a predetermined amount of nitrogen-containing gas in a furnace, whereby a plurality of nitrogen molecules in the nitrogen-containing gas replaces at least part of the oxygen molecules in the silicon oxide layer; and forming a polysilicon layer on the silicon oxide layer.

Abstract: An air supply system for a clean room with a critical machine. An intake duct connects the exterior of the clean room to a make-up air unit, and is configured to transport external air into the make-up air unit. A first air duct connects the make-up air unit to an air conditioning cabinet including a first chemical filter, and is configured to transport the air flowing through the make-up air unit into the air conditioning cabinet. The first chemical filter removes airborne molecular contamination from the air transported into the air conditioning cabinet. A second air duct connects the air conditioning cabinet to the critical machine, and is configured to transport the air flowing through the first chemical filter of the air conditioning cabinet into the critical machine. An exhaust duct connects the critical machine to the exterior of the clean room, discharging waste gas produced in the critical machine.

Abstract: This invention relates to a sheet membrane for repairing a damaged tissue. The membrane includes an isotropic layer of cross-linked biopolymeric fibers in which the fibers are 10 to 1,000 cm in length. This invention also relates to a method of making an isotropic layer of cross-linked biopolymeric fibers. The method includes: (1) coacervating biopolymeric fibers (e.g., collagen-based fibers) having lengths of less than 1 cm dispersed in an aqueous solution to obtain coacervated biopolymeric fibers having lengths of 10 to 1,000 cm; (2) flattening the coacervated biopolymeric fibers into a layer; (3) drying the layer; and (4) cross-linking the biopolymeric.

Abstract: A brightness enhancement film for use on a display includes a first substrate, a first light transmitting layer mounted on said first substrate, a second light transmitting layer mounted on said first light transmitting layer, a third light transmitting layer mounted between said first light transmitting layer and second light transmitting layer, and a second substrate mounted on said second light transmitting layer, wherein said first and said second light transmitting layer have a first and a second chiral character, respectively, and said third light transmitting layer has a wide-band chiral character.

Abstract: The invention provides a novel microorganism Pseudonocardia sp. RMRC PAH4 characterized in that it is able to degrade high concentration of quinoline by enrichment culture, shows a high tolerance to compactin-sodium and possesses a high hydroxylation activity of converting compactin-sodium to pravastatin-sodium. The invention relates also a process for converting compactin-sodium into pravastatin-sodium by fermenting said novel microorganism Pseudonocardia sp. RMRC PAH4. Pravastain-sodium is a potent cholesterol-lowering agent used in treatment for hypercholesterolemia.

Abstract: A purification process for manufacturing a high pure acarbose relates to a process for preparing high pure acarbose from acarbose-containing fermentation broth. The acarbose was purified through steps of alcohol precipitation, a strongly acidic cation exchanger chromatography and an immobilized enzyme affinity chromatography. Acarbose is generally applied in treating diabetes.

Abstract: A lid to selectively plug or unplug a discharge mouth of a developer container mounted to an image forming apparatus for replenishing a developer. In one embodiment of the present invention, the lid includes a body having a bottom portion and a sidewall portion defining an opening, wherein the bottom portion has an inner surface and an outer surface, and the sidewall portion has an inner surface and an outer surface. The lid additionally includes a lug having a first end and a second end defining a body portion, wherein the lug is engaged with the body at a position at the sidewall portion such that the second end of the lug and the first surface of the bottom portion define a gap g therebetween and the body portion of the lug facing away from the developer container when the lid plugs the discharge mouth.